Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias
Part of paid clinical trials in San Diego, California.
- Sponsor
- Goldman, Butterwick, Fitzpatrick and Groff
- Study ID
- NCT07342413
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Leg Veins
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Right leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine — DRUGRight leg treated with glycerin compounded with 1% lidocaine and epinephrine
- Left leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine — DRUGLeft leg treated with glycerin compounded with 1% lidocaine and epinephrine
Study Details
The primary objective is to compare physician-assessed clearance of telangiectatic veins between treatment legs using the Physician Global Aesthetic Improvement Scale (PGAIS). Secondary objectives include assessment of procedural pain, safety outcomes, and patient satisfaction.
Key Dates
- Start date
- Feb 1, 2026
- Status verified
- Jan 2026
- Primary completion
- May 30, 2026
- Completion
- Jul 30, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Active Comparator: Group A Right Leg Treated with glycerin compounded 1% lidocaine and epinephrineSubjects will be treated with foamed sodium tetradecyl sulfate (STS) to both legs. Four weeks later subjects left leg will be treated with glycerin compounded with 1% lidocaine, and right leg will be treated with glycerin compounded with 1% lidocaine and epinephrine.
- Sham Comparator: Group B Left Leg Treated with glycerin compounded 1% lidocaine and epinephrineSubjects will be treated with foamed sodium tetradecyl sulfate (STS) to both legs. Four weeks later subjects right leg will be treated with glycerin compounded with 1% lidocaine, and left leg will be treated with glycerin compounded with 1% lidocaine and epinephrine.
Primary Outcome Measure
Physician Global Aesthetic Improvement Scale PGAIS [ Time Frame: Day 90 ]
Central Contacts
- Andrea Pacheco858-657-1004
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| West Dermatology Research Center | San Diego | California | 92121 | - |
Find similar trials in San Diego, CA
By research site